Anti-Neuroinflammatory Potential of Areca Nut Extract and Its Bioactive Compounds in Anthracene-Induced BV-2 Microglial Cell Activation
Nutrients · 2024
DOI: 10.3390/nu16172882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Sakawrat Janpaijit und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Microglia, Plant Extracts, Anthracenes, Anti-Inflammatory Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science research and Innovation Fund Chulalongkorn University, Thailand Science Research and Innovation Fund, Chulalongkorn University.
Abstract (Originalsprache)
Particulate matter (PM2.5) containing polycyclic aromatic hydrocarbons (PAHs) is of considerable environmental importance worldwide due to its adverse effects on human health, which are associated with neurodegenerative diseases (NDDs). Areca catechu L. (AC) fruit is known to possess various pharmacological properties; however, the anti-neuroinflammatory roles of AC on the suppression of PAH-induced neuroinflammation are still limited. Thus, we focused on the effects and related signaling cascades of AC and its active compounds against anthracene-induced toxicity and inflammation in mouse microglial BV-2 cells. Phytochemicals in the ethanolic extract of AC (ACEE) were identified using LC-MS, and molecular docking was conducted to screen the interaction between compounds and target proteins. Significant bioactive compounds in ACEE such as arecoline, (−)-epicatechin, and syringic acid were evinced through the LC-MS spectrum. The docking study revealed that (−)-epicatechin showed the highest binding affinities against NF-κB. For cell-based approaches, anthracene induced intracellular ROS, mRNA levels of TNF-α, IL-1β, and IL-6, and the release of TNF-α through enhancing JNK, p38, and NF-κB signaling pathways. However, the co-treatment of cells with ACEE or (−)-epicatechin could reverse those anthracene-induced changes. The overall study suggested that ACEE-derived bioactive compounds such as (−)-epicatechin may be developed as a potential anti-neuroinflammatory agent by preventing inflammation-mediated NDDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Center of Excellence on Natural Products for Neuroprotection and Anti-Ageing (Neur-Age Natura), Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Food Toxicology Unit, Institute of Nutrition, Mahidol University, Salaya Campus, Phutthamonthon, Nakhon Pathom 73170, Thailand.
- Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
ORCID-Profile: Monruedee Sukprasansap, Tewin Tencomnao, Anchalee Prasansuklab
Förderung
- Thailand Science research and Innovation Fund Chulalongkorn University
- Thailand Science Research and Innovation Fund, Chulalongkorn University
Zitieren
APA
Janpaijit, S., Sukprasansap, M., Tencomnao, T., & Prasansuklab, A. (2024). Anti-Neuroinflammatory Potential of Areca Nut Extract and Its Bioactive Compounds in Anthracene-Induced BV-2 Microglial Cell Activation. Nutrients. https://doi.org/10.3390/nu16172882
Vancouver
Janpaijit S, Sukprasansap M, Tencomnao T, Prasansuklab A. Anti-Neuroinflammatory Potential of Areca Nut Extract and Its Bioactive Compounds in Anthracene-Induced BV-2 Microglial Cell Activation. Nutrients. 2024. doi:10.3390/nu16172882
BibTeX
@article{Janpaijit2024,
author = {Janpaijit, Sakawrat and Sukprasansap, Monruedee and Tencomnao, Tewin and Prasansuklab, Anchalee},
title = {Anti-Neuroinflammatory Potential of Areca Nut Extract and Its Bioactive Compounds in Anthracene-Induced BV-2 Microglial Cell Activation},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16172882}
}
EUVIMED